Oxford, UK, 18 July 2023 – PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients.
Long COVID is a debilitating chronic condition that has…
CAMBRIDGE, England & BOSTON, Jun. 23, 2023-- Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of
Alethia Young as its new Chief Financial Officer, effective July 17th.
Ms. Young joins Bicycle from Graphite Bio, where she served as Chief Financial Officer, and previously served as senior biotech analyst and head of research at Cantor Fitzgerald.
“We are…
Abzena have announced the recent appointment of Thomas Castellano as Chief Financial Office (CFO). Abzena is a leading biopharmaceutical company headquartered at Babraham Research Research Campus in Cambridge, UK. Last year, they opened a new biologics testing laboratory in San Diego, near their Biologics process development and manufacturing hub.
Castellano brings extensive financial expertise and strategic leadership to the company, having previously held the position of Senior Vice President, CFO at Catalent. His role as CFO will involve overseeing Abzena's financial…
AMSBIO, a leading supplier of human cell lines and research tools, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments.
The aim of the ADDONISS (Ageing and Degenerative Diseases of Neurons on the ISS) project is to conduct research on neuronal cell cultures in the microgravity environment of the International Space Station (ISS). AMSBIO’s…
Experts in translational oncology and targeted protein degradation join Dr Simon Cook, Dr Lorenz Mayr and Dr Catherine Beech to provide scientific and strategic oversight
Cambridge, UK, 17 July 2023: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB). Professor Parker and Dr Imbriglio will join existing SAB members, Dr Simon Cook (Institute Director, Babraham Institute and PhoreMost SAB Chair), Dr Lorenz Mayr (CEO, Vector Biopharma…
Anglia Ruskin University (ARU) and Writtle University College are delighted to announce a proposal to merge the two institutions.
The proposed merger will secure a long-term, sustainable future for Writtle, and unlock significant opportunities for growth and development by bringing together the two institutions’ strengths across education and research.
Now in its 130th year and located on the outskirts of Chelmsford, Writtle University College is one of the UK’s leading institutions for land-based studies.
It offers postgraduate, undergraduate, further education and short courses in the areas…
Leading science and innovation campus, Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. The programme will lay healthy foundations for future company success and equip early stage life science businesses with the skills needed when pitching to investors.
The free and hybrid programme running over the course of eight weeks, aims to ignite potential from the best of Discovery Park’s facilities, people and networks. Delivered in four in-person sessions, plus mentoring, networking and group learning, the sessions will cover teams…
Click here to view the July 2023 edition of The Meeting Place!
In this short video, Mike Davies, CEO of Carocell Bio, shares insights into their fascinating technology and how it could improve the lives of patients with anti-inflammatory peptides applied topically to the skin. This approach has great potential to treat and prevent the recurrence of eczema and has potential anti-ageing properties.
Watch the video
Interested in learning more? Visit their website: https://carocellbio.com/
Scaling up – how space is the key ingredient to superpower status
Much has been made of the government's plan to cement the UK as a Scientific Superpower, but beyond a title, what does this really entail? In short, it means opening the cheque book and making the UK more attractive to international talent and investment. This will enable the UK to build up its infrastructure and skill set – both of which are crucial for growing the industry. The physical, real estate, and various scientific infrastructure that sits alongside it, coupled with the workforce that occupies these buildings and…